We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Imaging and AI Aid Intraoperative Brain Tumor Diagnosis

By HospiMedica International staff writers
Posted on 15 Jan 2020
A workflow that combines advanced optical imaging with an artificial intelligence (AI) algorithm may accurately diagnose brain tumors in real time in the operating room, according to a new study.

Developed at the University of California, San Francisco (UCSF; USA), the University of Michigan (U-M; Ann Arbor, USA), Columbia University (New York, NY, USA), and other institutions, the novel parallel workflow combines stimulated Raman histology (SRH, a label-free optical imaging method), and deep convolutional neural networks (CNNs) to predict diagnosis in near real time in an automated fashion. More...
The CNNs, which were trained on over 2.5 million SRH images, built a hierarchy of recognizable histologic feature representations to help classify the major histopathologic classes of brain tumors.

The new workflow can diagnose brain tumors in less than 150 seconds, an order of magnitude faster than conventional histology techniques, which take 20–30 minutes. The authors also prospectively tested the workflow in a clinical trial of 278 patients with brain tumors, which demonstrated that the accuracy of CNN-based diagnosis of SRH images (94.6%) was slightly higher than pathologist-based interpretation of conventional histologic images (93.9%). The study was published on January 6, 2020, in Nature Medicine.

"As surgeons, we're limited to acting on what we can see; this technology allows us to see what would otherwise be invisible, to improve speed and accuracy in the operating room, and reduce the risk of misdiagnosis,” concluded lead author Todd Hollon, MD, of U-M, and colleagues. “Intraoperative cancer diagnosis can be streamlined, creating a complementary pathway for tissue diagnosis independent of a traditional pathology laboratory. With this imaging technology, cancer operations are safer and more effective than ever before.”

Related Links:
University of California, San Francisco
University of Michigan
Columbia University



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Portable Jaundice Management Device
Nymphaea
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.